Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Science Track

Impact of Gallium-68-DOTA-NOC PET/CT on Management Of Neuroendocrine tumors

Charu Jora
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 23;
Charu Jora
1Max Hospital Delhi India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 57 no. supplement 2 23

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2016.

Copyright & Usage 
© 2016

Author Information

  1. Charu Jora1
  1. 1Max Hospital Delhi India

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2016 to April 2025

AbstractFullPdf
May 2016400
Jun 20164000
Jul 20163100
Aug 20162400
Sep 20161000
Oct 20161300
Nov 20162600
Dec 20162100
Jan 20171600
Feb 20171700
Mar 20172000
Apr 20172600
May 20171300
Jun 20171500
Jul 2017900
Aug 20171600
Sep 2017800
Oct 2017800
Nov 2017800
Dec 20172000
Jan 2018500
Feb 20181100
Mar 2018900
Apr 2018200
May 2018400
Jun 2018100
Jul 2018100
Aug 20181000
Sep 2018500
Oct 2018400
Nov 2018500
Feb 2019100
Mar 2019300
Apr 2019200
Jul 2019100
Dec 2019200
Jan 2020100
Feb 2020500
Mar 20201700
Apr 2020900
May 20201000
Jun 2020200
Jul 2020100
Aug 20201300
Sep 20201700
Oct 20201500
Nov 20201900
Dec 20201000
Jan 2021100
Feb 2021800
Mar 2021900
Apr 2021800
May 20212000
Jun 20212100
Jul 20217400
Aug 20216900
Sep 20211100
Oct 20211700
Nov 20215000
Dec 20213300
Jan 20225700
Feb 20221600
Mar 20221000
Apr 2022400
May 20222100
Jun 2022300
Aug 2022200
Oct 2022100
Dec 2022200
Jan 2023200
Feb 2023100
Mar 2023200
Apr 2023300
May 2023400
Jun 2023300
Jul 2023100
Aug 2023200
Sep 2023300
Oct 2023200
Nov 2023200
Dec 2023300
Jan 2024800
Feb 2024100
Mar 2024200
Apr 2024200
May 2024800
Jun 2024300
Aug 2024500
Sep 2024800
Nov 2024300
Dec 2024400
Jan 2025100
Feb 2025800
Mar 2025500
Apr 2025600
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Gallium-68-DOTA-NOC PET/CT on Management Of Neuroendocrine tumors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Impact of Gallium-68-DOTA-NOC PET/CT on Management Of Neuroendocrine tumors
Charu Jora
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 23;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Impact of Gallium-68-DOTA-NOC PET/CT on Management Of Neuroendocrine tumors
Charu Jora
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 23;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Science Track

  • HIGH FDG UPTAKE ON PRE-RADIOTHERAPY PET/CT AND PREFERENTIAL SITES OF LOCAL RELAPSE AFTER CHEMORADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER
  • Usefulness of the total lesion glycolysis (TLG) ratio in predicting the therapeutic effect of head and neck cancer-A novel parameter-
  • Early response monitoring with 18F-FDG PET/CT after Chemoradiotherapy with Cetuximab in head and neck Squamous Cell Carcinoma Patients (HNSCC)
Show more Oncology, Clinical Science Track

Other Tumors (NET and Others)

  • First-Time-in-Human Trial of Cu-64 MeCOSAR-octreotate (CuSARTATE) for Imaging and Dosimetry Estimation in Neuroendocrine Tumor (NET)
  • Update of the prospective impact on management study using 68Ga-DOTATATE PET/CT in neuroendocrine tumor patients: the referring physician's perspective
Show more Other Tumors (NET and Others)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire